RU2543622C2 - Способ получения азабициклических соединений - Google Patents
Способ получения азабициклических соединений Download PDFInfo
- Publication number
- RU2543622C2 RU2543622C2 RU2012115111/04A RU2012115111A RU2543622C2 RU 2543622 C2 RU2543622 C2 RU 2543622C2 RU 2012115111/04 A RU2012115111/04 A RU 2012115111/04A RU 2012115111 A RU2012115111 A RU 2012115111A RU 2543622 C2 RU2543622 C2 RU 2543622C2
- Authority
- RU
- Russia
- Prior art keywords
- compound
- formula
- solvent
- contacting
- mixture
- Prior art date
Links
- AJDUFGPZEKPRSU-MGCOHNPYSA-N CC(C)(C)OC(N[C@H](CC1)CC[C@@H]1OS(C)(=O)=O)=O Chemical compound CC(C)(C)OC(N[C@H](CC1)CC[C@@H]1OS(C)(=O)=O)=O AJDUFGPZEKPRSU-MGCOHNPYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
- C07B61/02—Generation of organic free radicals; Organic free radicals per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24347709P | 2009-09-17 | 2009-09-17 | |
| US61/243,477 | 2009-09-17 | ||
| PCT/US2010/049306 WO2011035139A1 (en) | 2009-09-17 | 2010-09-17 | Process for preparing azabicyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012115111A RU2012115111A (ru) | 2013-10-27 |
| RU2543622C2 true RU2543622C2 (ru) | 2015-03-10 |
Family
ID=43242763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012115111/04A RU2543622C2 (ru) | 2009-09-17 | 2010-09-17 | Способ получения азабициклических соединений |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8404865B2 (OSRAM) |
| EP (1) | EP2477991B1 (OSRAM) |
| JP (1) | JP5793496B2 (OSRAM) |
| KR (1) | KR20120083416A (OSRAM) |
| CN (1) | CN102498112B (OSRAM) |
| AU (1) | AU2010295461B2 (OSRAM) |
| BR (1) | BR112012006031A2 (OSRAM) |
| CA (1) | CA2772792A1 (OSRAM) |
| ES (1) | ES2540810T3 (OSRAM) |
| IL (1) | IL218641A0 (OSRAM) |
| MX (1) | MX2012003343A (OSRAM) |
| NZ (1) | NZ598277A (OSRAM) |
| RU (1) | RU2543622C2 (OSRAM) |
| WO (1) | WO2011035139A1 (OSRAM) |
| ZA (1) | ZA201201252B (OSRAM) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1898221A (zh) | 2003-09-06 | 2007-01-17 | 沃泰克斯药物股份有限公司 | Atp－结合弹夹转运蛋白的调控剂 |
| US7407976B2 (en) * | 2003-11-14 | 2008-08-05 | Vertex Pharmaceuticals Incorporated | Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters |
| US7977322B2 (en) | 2004-08-20 | 2011-07-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| HUE032540T2 (en) | 2004-06-24 | 2017-09-28 | Vertex Pharma | Modulators of ATP-binding cassette transporters |
| ATE512145T1 (de) | 2005-08-11 | 2011-06-15 | Vertex Pharma | Modulatoren des cystic fibrosis transmembrane conductance regulators |
| EP2395002B1 (en) | 2005-11-08 | 2014-06-18 | Vertex Pharmaceuticals Inc. | Pharmaceutical composition containing a heterocyclic modulator of atp-binding cassette transporters. |
| CN101395147B (zh) | 2005-12-28 | 2013-05-29 | 弗特克斯药品有限公司 | 作为atp-结合盒转运蛋白调节剂用于治疗囊性纤维化的1-(苯并[d][1,3]间二氧杂环戊烯-5-基)-n-(苯基)环丙烷-甲酰胺衍生物及相关化合物 |
| CA2635581C (en) | 2005-12-28 | 2017-02-28 | Vertex Pharmaceuticals Incorporated | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| PT2674428T (pt) | 2006-04-07 | 2016-07-14 | Vertex Pharma | Modeladores de transportadores de cassetes de ligação de atp |
| USRE50453E1 (en) | 2006-04-07 | 2025-06-10 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| US10022352B2 (en) | 2006-04-07 | 2018-07-17 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| US7645789B2 (en) | 2006-04-07 | 2010-01-12 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
| NZ581259A (en) | 2007-05-09 | 2012-07-27 | Vertex Pharma | Modulators of cystic fibrosis transmembrane conductance regulator |
| HUE028426T2 (en) | 2007-08-24 | 2016-12-28 | Vertex Pharma | Isothiazolopyridinones for (inter alia) treating cystic fibrosis |
| ES2556080T3 (es) | 2007-11-16 | 2016-01-12 | Vertex Pharmaceuticals Incorporated | Moduladores de isoquinolina de transportadores de casete de unión a ATP |
| US20100036130A1 (en) | 2007-12-07 | 2010-02-11 | Vertex Pharmaceuticals Incorporated | Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
| UA95199C2 (en) * | 2007-12-07 | 2011-07-11 | Вертекс Фармасьютикалз Инкорпорейтед | Aqueous formulation of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| LT2639223T (lt) | 2007-12-07 | 2017-06-26 | Vertex Pharmaceuticals Incorporated | Cikloalkilkarboksiamido-piridino benzenkarboksirūgščių gamybos būdas |
| UA102534C2 (xx) | 2007-12-07 | 2013-07-25 | Вертекс Фармасьютикалз Инкорпорейтед | ТВЕРДА ФОРМА 3-(6-(1-(2,2-ДИФТОРБЕНЗО$d]$1,3]-ДІОКСОЛ-5-ІЛ)-ЦИКЛОПРОПАНКАРБОКСАМІДО)-3-МЕТИЛПІРИДИН-2-ІЛ)БЕНЗОЙНОЇ КИСЛОТИ (ВАРІАНТИ)$ТВЕРДАЯ ФОРМА 3-(6-(1-(2,2-ДИФТОРБЕНЗО$d]$1,3]-ДИОКСОЛ-5-ИЛ)-ЦИКЛОПРОПАНКАРБОКСАМИДО)-3-МЕТИЛПИРИДИН-2-ИЛ)БЕНЗОЙНОЙ КИСЛОТЫ (ВАРИАНТЫ) |
| NZ602030A (en) | 2008-02-28 | 2014-02-28 | Vertex Pharma | Heteroaryl derivatives as cftr modulators |
| NZ616097A (en) | 2008-03-31 | 2015-04-24 | Vertex Pharma | Pyridyl derivatives as cftr modulators |
| US12458635B2 (en) | 2008-08-13 | 2025-11-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| MX2011003249A (es) * | 2008-09-29 | 2011-05-19 | Vertex Pharma | Unidades de dosificacion del acido 3-(6-(1-(2,2-difluorobenzo[d][1 ,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benzoi co. |
| AR074060A1 (es) | 2008-10-23 | 2010-12-22 | Vertex Pharma | Moduladores del regulador de conductancia transmembrana de la fibrosis quistica |
| EP2821400B1 (en) | 2009-03-20 | 2017-09-27 | Vertex Pharmaceuticals Incorporated | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| KR20120083416A (ko) * | 2009-09-17 | 2012-07-25 | 버텍스 파마슈티칼스 인코포레이티드 | 아자비시클릭 화합물의 제조 방법 |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| NZ602795A (en) | 2010-04-07 | 2015-01-30 | Vertex Pharma | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| CN102917692A (zh) | 2010-04-07 | 2013-02-06 | 弗特克斯药品有限公司 | 3-(6-(1-(2,2-二氟苯并[d][1,3]二氧杂环戊烯-5-基)环丙甲酰胺基)-3-甲基吡啶-2-基)苯甲酸的药物组合物和其给药方法 |
| CA2797118C (en) | 2010-04-22 | 2021-03-30 | Vertex Pharmaceuticals Incorporated | Process of producing cycloalkylcarboxamido-indole compounds |
| EP2560650A1 (en) | 2010-04-22 | 2013-02-27 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions and administrations thereof |
| NZ603042A (en) | 2010-04-22 | 2015-02-27 | Vertex Pharma | Pharmaceutical compositions comprising cftr modulators and administrations thereof |
| US8563593B2 (en) | 2010-06-08 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide |
| AU2012335714B2 (en) | 2011-11-08 | 2017-04-13 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| RU2692779C2 (ru) | 2012-02-27 | 2019-06-27 | Вертекс Фармасьютикалз Инкорпорейтед | Фармацевтическая композиция и ее введения |
| CN102633804B (zh) * | 2012-04-19 | 2014-09-24 | 中南大学 | 一种制备7-氮杂双环[2.2.1]庚烷的方法 |
| US8674108B2 (en) | 2012-04-20 | 2014-03-18 | Vertex Pharmaceuticals Incorporated | Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| AU2013290444B2 (en) | 2012-07-16 | 2018-04-26 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof |
| BR112016010403A2 (pt) | 2013-11-12 | 2017-08-08 | Vertex Pharma | Processo de preparação de composições farmacêuticas para o tratamento de doenças mediadas por cftr |
| CA2944140C (en) | 2014-04-15 | 2022-10-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases |
| RU2749213C2 (ru) | 2014-10-07 | 2021-06-07 | Вертекс Фармасьютикалз Инкорпорейтед | Сокристаллы модуляторов регулятора трансмембранной проводимости при кистозном фиброзе |
| US10302602B2 (en) | 2014-11-18 | 2019-05-28 | Vertex Pharmaceuticals Incorporated | Process of conducting high throughput testing high performance liquid chromatography |
| CR20230120A (es) | 2020-08-07 | 2023-09-01 | Vertex Pharma | Moduladores del regulador de la conductancia transmembrana de la fibrosis quística |
| US12324802B2 (en) | 2020-11-18 | 2025-06-10 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006077497A1 (en) * | 2005-01-21 | 2006-07-27 | Pfizer Limited | Crystalline forms cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido) cyclohexyl]-2-(tetrahydrothiopyran-a-yloxy) nicotinamide |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6060473A (en) | 1993-04-01 | 2000-05-09 | Ucb S.A. - Dtb | 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands |
| JPH06312989A (ja) * | 1993-04-30 | 1994-11-08 | Nippon Chemiphar Co Ltd | （１ｒｓ，２ｒｓ，４ｓｒ）−２−（６−クロロ−３−ピリジル）−７−アザビシクロ［２．２．１］ヘプタンの製造方法 |
| US6117889A (en) | 1994-04-01 | 2000-09-12 | University Of Virginia | 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents |
| TW200407127A (en) * | 2002-08-21 | 2004-05-16 | Astrazeneca Ab | Chemical compounds |
| EP1730155A1 (en) * | 2004-02-20 | 2006-12-13 | AstraZeneca AB | Thienopyrroles as antagonists of gnrh |
| HUE032540T2 (en) * | 2004-06-24 | 2017-09-28 | Vertex Pharma | Modulators of ATP-binding cassette transporters |
| WO2008117871A1 (ja) * | 2007-03-28 | 2008-10-02 | Nagasaki University | 含窒素レドックス触媒 |
| NZ592504A (en) * | 2008-10-23 | 2013-04-26 | Vertex Pharma | Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide |
| AR074060A1 (es) * | 2008-10-23 | 2010-12-22 | Vertex Pharma | Moduladores del regulador de conductancia transmembrana de la fibrosis quistica |
| KR20120083416A (ko) * | 2009-09-17 | 2012-07-25 | 버텍스 파마슈티칼스 인코포레이티드 | 아자비시클릭 화합물의 제조 방법 |
| JP5789611B2 (ja) * | 2009-10-23 | 2015-10-07 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | 嚢胞性線維症膜コンダクタンス制御因子のモジュレーターを調製するためのプロセス |
| US8389727B2 (en) * | 2009-10-23 | 2013-03-05 | Vertex Pharmaceuticals Incorporated | Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| US8404849B2 (en) * | 2010-05-20 | 2013-03-26 | Vertex Pharmaceuticals | Processes for producing modulators of cystic fibrosis transmembrane conductance regulator |
-
2010
- 2010-09-17 KR KR1020127009689A patent/KR20120083416A/ko not_active Withdrawn
- 2010-09-17 US US12/884,925 patent/US8404865B2/en active Active
- 2010-09-17 ES ES10757544.1T patent/ES2540810T3/es active Active
- 2010-09-17 WO PCT/US2010/049306 patent/WO2011035139A1/en not_active Ceased
- 2010-09-17 AU AU2010295461A patent/AU2010295461B2/en not_active Expired - Fee Related
- 2010-09-17 CA CA2772792A patent/CA2772792A1/en not_active Abandoned
- 2010-09-17 CN CN201080041222.8A patent/CN102498112B/zh not_active Expired - Fee Related
- 2010-09-17 JP JP2012529933A patent/JP5793496B2/ja not_active Expired - Fee Related
- 2010-09-17 NZ NZ598277A patent/NZ598277A/en not_active IP Right Cessation
- 2010-09-17 RU RU2012115111/04A patent/RU2543622C2/ru not_active IP Right Cessation
- 2010-09-17 MX MX2012003343A patent/MX2012003343A/es active IP Right Grant
- 2010-09-17 EP EP10757544.1A patent/EP2477991B1/en not_active Not-in-force
- 2010-09-17 BR BR112012006031A patent/BR112012006031A2/pt not_active IP Right Cessation
-
2012
- 2012-02-20 ZA ZA2012/01252A patent/ZA201201252B/en unknown
- 2012-03-09 US US13/416,157 patent/US8461352B2/en not_active Expired - Fee Related
- 2012-03-14 IL IL218641A patent/IL218641A0/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006077497A1 (en) * | 2005-01-21 | 2006-07-27 | Pfizer Limited | Crystalline forms cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido) cyclohexyl]-2-(tetrahydrothiopyran-a-yloxy) nicotinamide |
Non-Patent Citations (1)
| Title |
|---|
| Canadion J. of Chemistry, 1970, 48, 13, p.2065-2074. * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011035139A1 (en) | 2011-03-24 |
| EP2477991B1 (en) | 2015-04-15 |
| EP2477991A1 (en) | 2012-07-25 |
| IL218641A0 (en) | 2012-05-31 |
| RU2012115111A (ru) | 2013-10-27 |
| HK1169106A1 (en) | 2013-01-18 |
| AU2010295461A1 (en) | 2012-03-08 |
| BR112012006031A2 (pt) | 2019-09-24 |
| AU2010295461B2 (en) | 2016-03-03 |
| US20120259129A1 (en) | 2012-10-11 |
| CN102498112A (zh) | 2012-06-13 |
| US8461352B2 (en) | 2013-06-11 |
| ES2540810T3 (es) | 2015-07-13 |
| ZA201201252B (en) | 2013-05-29 |
| US8404865B2 (en) | 2013-03-26 |
| JP2013505259A (ja) | 2013-02-14 |
| JP5793496B2 (ja) | 2015-10-14 |
| CA2772792A1 (en) | 2011-03-24 |
| CN102498112B (zh) | 2015-05-20 |
| KR20120083416A (ko) | 2012-07-25 |
| MX2012003343A (es) | 2012-08-17 |
| US20110065928A1 (en) | 2011-03-17 |
| NZ598277A (en) | 2014-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2543622C2 (ru) | Способ получения азабициклических соединений | |
| EP3681862B1 (en) | Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia | |
| KR20150028971A (ko) | 항바이러스성 화합물의 고체 형태 | |
| US7732470B2 (en) | Compositions and methods for the treatment of renal and cardiovascular disease | |
| CN103827108B (zh) | 丙型肝炎病毒抑制剂 | |
| RS53292B (sr) | Kristalni oblici 2-tiazolil-4-hinolinil-oksi derivata, snažni hcv inhibitor | |
| KR20010041533A (ko) | (2ｅ)-5-아미노-5-메틸헥스-2-엔오산ｎ-메틸-ｎ-((1ｒ)-1-(ｎ-메틸-ｎ-((1ｒ)-1-(메틸카르바모일)-2-페닐에틸)카르바모일)-2-(2-나프틸)에틸)아미드의신규한 염 형태 | |
| CN120360979A (zh) | 小分子化合物在心血管疾病治疗中的应用 | |
| US8071594B2 (en) | Substituted diketopiperazines and their use as oxytocin antagonists | |
| JPH07500604A (ja) | 高血圧治療用エチルアラニンアミノジオール化合物 | |
| CN112047993A (zh) | 一种α-葡萄糖苷酶抑制剂及其用途 | |
| JP2011524915A (ja) | （１ｒ，２ｓ，３ｒ）−１−（２−（イソオキサゾール−３−イル）−１ｈ−イミダゾール−４−イル）ブタン−１，２，３，４−テトラオールの固体形態及びその使用方法 | |
| JPH0536436B2 (OSRAM) | ||
| TWI399374B (zh) | 新穎晶體形式及製備方法以及其醫藥組合物 | |
| CN119350175A (zh) | 一类新型酰基苯丙氨酸衍生物、其制备方法及其作为药物的用途 | |
| CN118178369A (zh) | 氨基硫醇类化合物作为脑神经或心脏保护剂的用途 | |
| CA2700936A1 (en) | Production method for pyrazol-3-yl-benzamide derivative | |
| WO2001005750A1 (fr) | COMPOSES DE p-TERPHENYLE A CHAINES LATERALES D'ACYLOXYMETHOXYCARBONYLE | |
| HK1169106B (zh) | 製備氮雜二環化合物的方法 | |
| WO2025067474A1 (zh) | 一种含吡啶的化合物及其制备方法和用途 | |
| JP2023549962A (ja) | Ｐｕ．１阻害剤としての化合物 | |
| WO2001064661A1 (en) | Antioxidants | |
| JPH09110691A (ja) | 医薬組成物 | |
| Takahashi et al. | 19, United States i, Patent Application Publication | |
| JPH089593B2 (ja) | 環状エノ−ル誘導体およびその製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160918 |